PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
The current price of 2PV.F is €3.67 EUR — it has increased by +0% in the past 24 hours. Watch POLYPID LTD. O.N. stock price performance more closely on the chart.
What is POLYPID LTD. O.N. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange POLYPID LTD. O.N. stocks are traded under the ticker 2PV.F.
When is the next POLYPID LTD. O.N. earnings date?▼
POLYPID LTD. O.N. is going to release the next earnings report on May 13, 2026.
What were POLYPID LTD. O.N. earnings last quarter?▼
2PV.F earnings for the last quarter are -0.35 EUR per share, whereas the estimation was -0.28 EUR resulting in a -24.24% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does POLYPID LTD. O.N. have?▼
As of April 01, 2026, the company has 57 employees.
In which sector is POLYPID LTD. O.N. located?▼
POLYPID LTD. O.N. operates in the Health Care sector.
When did POLYPID LTD. O.N. complete a stock split?▼
POLYPID LTD. O.N. has not had any recent stock splits.
Where is POLYPID LTD. O.N. headquartered?▼
POLYPID LTD. O.N. is headquartered in Petah Tikva, IL.